Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens Advertising Group has announced new self-serve programmatic and clean-room solutions for brand advertisers. These solutions enable advertisers to utilize Walgreens' first-party data on their chosen demand-side platforms (DSPs). The offerings aim to enhance campaign management and deliver personalized ads, leveraging over 95 million myWalgreens members and 1 billion daily touchpoints. Advertisers will access these solutions in Q2, optimizing campaigns through closed-loop reporting. Customer privacy remains a priority, featuring data confidentiality within the new service.
Walgreens (WBA) has partnered with Western Dental & Orthodontics and the NFL Alumni Association to offer free COVID-19 vaccines, boosters, and rapid tests at an event in Inglewood, California, on February 12. The initiative aims to address the vaccination gap in vulnerable communities which lag by as much as 30% compared to affluent areas. The event will also feature former NFL players, giveaways, and resources to improve health access. Vaccines and tests will be administered by licensed professionals, supporting community health ahead of the big game on February 13.
Walgreens Boots Alliance (WBA) announced the appointment of Steven J. Shulman to its board of directors, effective January 27, 2022. Bringing a wealth of healthcare management experience and an extensive background in emerging healthcare technologies, Shulman is expected to provide valuable insights as WBA continues to enhance local healthcare delivery. His previous leadership roles include CEO of Magellan Health Services. Executive Chairman Stefano Pessina and CEO Roz Brewer expressed confidence in Shulman's contributions towards the company’s consumer-centric healthcare strategy.
Walgreens Boots Alliance (WBA) has declared a quarterly dividend of 47.75 cents per share, unchanged from the last quarter but up 2.1% from the same quarter last year. The dividend will be payable on March 11, 2022, to stockholders of record by February 18, 2022. WBA has consistently paid dividends for 357 quarters and increased it for 46 consecutive years, reinforcing its commitment to shareholder returns.
Walgreens has launched the 12th Annual Expressions competition for high school students, promoting creativity as a means to address mental health issues. The contest invites submissions in visual arts, video production, and spoken word, with $2,000 prizes for each of the 12 winners. The initiative aligns with concerns raised by the U.S. Surgeon General regarding youth mental health, exacerbated by the pandemic. Since 2009, the program has reached 1 million students and awarded over $350,000 in prizes. Submissions are open until March 31, 2022.
Walgreens Boots Alliance (WBA) announces the opening of eight new Village Medical at Walgreens locations in Tucson, Arizona, by the end of 2022, creating 285 full-time jobs, including 140 STEM roles. These openings enhance access to primary care for over 3 million Arizonans, addressing a significant doctor shortage. The investment aims to expand its primary care services, with plans to launch over 600 Village Medical practices by 2025. This collaborative approach between VillageMD and Walgreens is expected to improve healthcare access and patient outcomes.
The Walgreens COVID-19 Index, a new tracking tool created in partnership with Aegis Sciences Corporation, provides real-time data on COVID-19 variants. Currently, over 95% of positive cases are presumed to be the Omicron variant. The Index can deliver insights within 24 to 48 hours and allows users to review data by state. Key states report positivity rates exceeding 45%. Walgreens emphasizes the importance of vaccinations and offers them at nearly 9,000 locations.
Walgreens Boots Alliance (WBA) reported strong first-quarter results for fiscal 2022, with earnings per share (EPS) from continuing operations at $4.13, recovering from a loss of $0.45 last year. Sales increased 7.8% to $33.9 billion, while operating income rose to $1.3 billion compared to a loss in the previous year. The company has raised its full-year adjusted EPS guidance, anticipating low-single digit growth. Highlights included significant growth in U.S. retail comparable sales and effective COVID-19 vaccination efforts, with over 15.6 million administered in the quarter.
Walgreens Boots Alliance (NASDAQ: WBA) announced that CEO Roz Brewer and CFO James Kehoe will speak at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11 at 2:15 p.m. ET. The virtual event will be webcast live, accessible on the Walgreens investor relations website. With a 170-year legacy, WBA operates approximately 13,000 locations across the U.S., Europe, and Latin America, focusing on integrating healthcare, pharmacy, and retail services to enhance community well-being.
Walgreens and Faith for Black Lives have launched the 'Shots for Tots' initiative to promote COVID-19 vaccination among children and families in underserved communities. Starting on December 18, this campaign includes on-site vaccination clinics at churches across 10 states, aiming to address vaccine hesitancy, especially among Black youths. The partnership seeks to encourage vaccinations for individuals of all ages while also hosting toy drives this holiday season. This effort highlights the critical role faith leaders play in improving vaccine access within their communities.